...
首页> 外文期刊>Intensive care medicine >Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.
【24h】

Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.

机译:内毒素兔对精氨酸加压素的全身和肝内大剂量和微循环剂量反应。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Arginine vasopressin (AVP) is being used increasingly to treat vasodilatory hypotension, although its effects on hepatosplanchnic perfusion have been debated. DESIGN: Prospective study in a university-based experimental research laboratory. SUBJECTS AND INTERVENTIONS: We compared the effect of AVP on systemic, gut, and liver blood flow in anesthetized and ventilated rabbits given either saline or endotoxin. Incremental i.v. boluses of AVP ranging from 1 to 1,000[Symbol: see text]ng were administered 90[Symbol: see text]min post-endotoxin or saline. MEASUREMENTS AND RESULTS: Endotoxin induced a shock state with a transient decrease of mesenteric artery blood flow velocity (pulsed Doppler, in centimeters per second, V(mes)) but had no effect on liver surface microcirculation (laser Doppler in TPU, MicroFl(liver)). Gut microcirculatory (MicroFl(gut)) changes became independent of mean arterial pressure (MAP) after endotoxin. In control rabbits (n = 5), increasing doses of AVP elevated MAP but reduced aortic blood flow (pulsed Doppler, VAo), V(mes), and MicroFl(gut) (p < 0.05). In endotoxic animals (n = 6), AVP produced a similar rise in MAP (p < 0.05), while V(mes) and MicroFl(gut) only decreased for AVP doses above 100[Symbol: see text]ng (p < 0.05). Liver microcirculation was only minimally affected by AVP, although significantly, both in control and endotoxin animals. CONCLUSION: Preservation of mesenteric blood flow as well as gut and liver microcirculation, with therapeutic doses of AVP during endotoxemia, supports its use as a hemodynamic agent during septic shock.
机译:目的:精氨酸血管加压素(AVP)正被越来越多地用于治疗血管扩张性低血压,尽管其对肝内脏灌注的影响已有争议。设计:在基于大学的实验研究实验室中进行前瞻性研究。受试者和干预措施:我们比较了AVP对麻醉或通气的生理盐水或内毒素兔的全身,肠道和肝脏血流的影响。增量式i.v.内毒素或生理盐水后90分钟内,每次注射AVP的剂量范围为1到1,000 [ng]。测量和结果:内毒素诱发休克状态,肠系膜动脉血流速度瞬时降低(脉冲多普勒,以厘米/秒为单位,V(mes)),但对肝表面微循环没有影响(TPU中的激光多普勒,MicroFl(肝) ))。内毒素后,肠道微循环(MicroFl(gut))的变化变得独立于平均动脉压(MAP)。在对照兔(n = 5)中,增加AVP剂量可提高MAP,但减少主动脉血流量(脉冲多普勒,VAo),V(mes)和MicroF1(肠)(p <0.05)。在内毒素动物(n = 6)中,AVP产生了类似的MAP升高(p <0.05),而V(mes)和MicroFl(gut)仅在AVP剂量高于100 [ng]时才降低(p <0.05 )。在对照组和内毒素动物中,肝微循环受AVP的影响很小,尽管影响很大。结论:内毒素血症期间使用治疗剂量的AVP可以保持肠系膜血流以及肠道和肝脏微循环,支持其在败血性休克期间用作血流动力学药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号